Tom Ketas

Cornell University — United States

Immunology and Microbiology · Life Sciences

10h-index1.8kcitations10works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(10), Immune Cell Function and Interaction(7), HIV/AIDS drug development and treatment(5), HIV/AIDS Research and Interventions(3), T-cell and B-cell Immunology(1)

Publications10 total

The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by a Single Amino Acid Difference and Suggests a Mechanism of Action for These Inhibitors
Journal of Virology·2004· 42 citedOpen Access
Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry
Journal of Virology·2003· 204 citedOpen Access
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
Nature Medicine·2003· 458 cited
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
Proceedings of the National Academy of Sciences·2002· 303 citedOpen Access
HIV Type 1 Molecular Clones Able to Use the Bonzo/STRL-33 Coreceptor for Virus Entry
AIDS Research and Human Retroviruses·2001· 18 cited
The Effect of Highly Active Antiretroviral Therapy on Binding and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Infection
The Journal of Infectious Diseases·2000· 72 cited
A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor
Journal of Virology·1999· 182 citedOpen Access
HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
Journal of Clinical Investigation·1999· 237 citedOpen Access
The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity
Journal of Virology·1999· 106 citedOpen Access
Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage
Journal of Virology·1998· 162 citedOpen Access

Frequent Co-authors

John P. Moore(9), Alexandra Trkola(8), Shawn E. Kuhmann(3), Bahige M. Baroudy(3), James Μ. Binley(3), Elizabeth S. Maxwell(2), Pavel Pugach(2), Jayaram R. Tagat(2), John W. Clader(2), Stuart W. McCombie(2), Gregory R. Reyes(2), Brian Clas(2), Linqi Zhang(2), Arlene Hurley(2), Christoph Seibert(2), Thomas P. Sakmar(2), Jamie D. Matthews(2), Cynthia J. Gordon(2), Ronald S. Veazey(1), Robin J. Shattock(1)